| 1 |
33403775 | Compassionate use of ruxolitinib in patients with SARS-Cov-2 infection not on mechanical ventilation: Short-term effects on inflammation and ventilation. | 2021 May |
1 |
| 2 |
31654094 | Potent repression of C-reactive protein (CRP) expression by the JAK1/2 inhibitor ruxolitinib in inflammatory human hepatocytes. | 2020 Jan |
6 |
| 3 |
29508247 | Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies. | 2018 Aug |
1 |
| 4 |
29675680 | A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation. | 2018 Aug |
1 |
| 5 |
25441108 | A phase I/II study of the Janus kinase (JAK)1 and 2 inhibitor ruxolitinib in patients with relapsed or refractory acute myeloid leukemia. | 2015 Mar |
2 |
| 6 |
26351344 | Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed. | 2015 Dec 1 |
1 |
| 7 |
26463833 | Ruxolitinib Benefits Some with Pancreatic Cancer. | 2015 Dec |
1 |